Search

Your search keyword '"Koopmans, Marion P."' showing total 1,277 results

Search Constraints

Start Over You searched for: Author "Koopmans, Marion P." Remove constraint Author: "Koopmans, Marion P."
1,277 results on '"Koopmans, Marion P."'

Search Results

2. An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution

Catalog

Books, media, physical & digital resources

5. Author Correction: Time-series sewage metagenomics distinguishes seasonal, human-derived and environmental microbial communities potentially allowing source-attributed surveillance

7. Time-series sewage metagenomics distinguishes seasonal, human-derived and environmental microbial communities potentially allowing source-attributed surveillance

11. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

12. Correction: The One Health High-Level Expert Panel (OHHLEP)

13. Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients

17. The panzootic spread of highly pathogenic avian influenza H5N1 sublineage 2.3.4.4b: a critical appraisal of One Health preparedness and prevention

18. The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic

19. Defining the risk of SARS-CoV-2 variants on immune protection

20. The One Health High-Level Expert Panel (OHHLEP)

21. Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up

23. Combining epidemiological data and whole genome sequencing to understand SARS-CoV-2 transmission dynamics in a large tertiary care hospital during the first COVID-19 wave in The Netherlands focusing on healthcare workers

24. Untangling introductions and persistence in COVID-19 resurgence in Europe

26. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

27. Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial

28. An early warning system for emerging SARS-CoV-2 variants

29. A pan-orthohantavirus human lung xenograft mouse model and its utility for preclinical studies.

30. A three-dimensional vessel-on-chip model to study Puumala orthohantavirus pathogenesis.

35. SARS-CoV-2 outbreaks in secondary school settings in the Netherlands during fall 2020; silent circulation

38. mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial

40. Virus genomes reveal factors that spread and sustained the Ebola epidemic

44. Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.

45. COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study

48. Effectiveness of Passive and Active Surveillance for Early Detection of SARS-CoV-2 in Mink during the 2020 Outbreak in the Netherlands